Skip to main content
Clinical Trials/NCT04194333
NCT04194333
Completed
Not Applicable

Comparing Diagnostic Yield of Electromagnetic Navigational Bronchoscopy Guided With Real Time Cone Beam Computer Tomography With Standard Fluoroscopy Guidance for Peripheral and Central Lung Lesions

Columbus Regional Health1 site in 1 country180 target enrollmentAugust 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lung Nodule
Sponsor
Columbus Regional Health
Enrollment
180
Locations
1
Primary Endpoint
Diagnostic Yield
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Electromagnetic navigation bronchoscopy (ENB) is used to access peripheral and central parenchymal lung lesions via endobronchial and transbronchial approach. Traditionally ENB is done under fluoroscopic guidance using C-arm but with development of Cone Beam CT and 3D reconstruction technology, fluoroscopy can be enhanced to much higher resolution and can also provide real time 3D augmentation of the lesion. It also enables the user to obtain a CT of the Chest to confirm the real time location of the lesion and the bronchoscopic biopsy catheter and instruments. This is thought to improve the yield and sensitivity of ENB guided Biopsy of the lung nodules and masses but has not been proven in a prospective trial. With my study, I want to examine the effect of Cone Beam CT with 3D reconstruction on the diagnostic yield and sensitivity of Electromagnetic Navigational Bronchoscopic biopsy of the lung lesions.

Detailed Description

Electromagnetic navigation bronchoscopy has been used for more than a decade to access peripheral and central parenchymal lung lesions bronchoscopically. Traditionally standard fluoroscopy using C-arm is used to confirm the location and guide the biopsy instruments under real-time guidance. With availability of Cone Beam CT, fluoroscopic images of much higher quality and resolution can be obtained intra-operatively. It also enables the bronchoscopist to obtain intraoperative CT images and confirm the exact location of the lesion and the Bronchoscopic biopsy catheter or the biopsy instruments. At my institution, lung nodules/masses requiring ENB have been approached using Medtronic Super-Dimension Version 7 Electromagnetic Navigational Bronchoscopy system. All the procedures are done under fluroscopic guidance using a regular C-Arm. All the lesions are confirmed using peripheral Endobronchial Ultrasound (EBUS). Once the appropriate location is reached, biopsy is obtained using FNA (18G or 21G), Single or Triple needle brush, Transbronchial forceps and Bronchoalveolar lavage. A pathologist is present on site for all the cases to review the slides and assist in diagnosis. All the cases are done under general anesthesia through endotracheal tube. Also, all the ENB procedures have been performed by one Interventional Pulmonologist since August 2017. For the interventional arm, all the aspects will remain the same except that the cases are done in Hybrid OR instead of Endoscopy. All the patients are completely paralyzed intra-operatively. Also, instead of a standard C-Arm providing 2D fluoroscopic guidance, a Philips Azurion 7 C20 FlexMove system with Emboguide, 3D Segmentaion and Overlay tools is being used. This enables the bronchoscopist to obtain a CT scan of the chest and also segment out the lesion(s) of interest and to overlap the 3-D image of the lesion on live fluoroscopy in all 3 dimensions. During the ENB procedures, at least 1 full Xpert CT is going to be obtained, mostly after completing the airway registration and ENB guided approach the lesion. Once the extended working channel and the locatable guide is advanced to the lesion using ENB guidance, the catheter is locked and scope held in place. The patient is maintained in inspiratory breath hold and Cone Beam Ct is used to obtain the Xpert CT that shows the lesion and surrounding lungs, chest and mediastinal structures in the surrounding area of the chest. This is then used to analyze the location of the lesion and the lesion of the extended working channel, locatable guide and the biopsy instruments in relation to the lesion. The lesion is then segmented and EmboGuide+Overlay feature is used to project a 3D view of the lesion on the live fluoroscopic images in all three axis. This also allows the bronchoscopist to obtain Anterior-posterior, Lateral and oblique views at various angles while maintaining the 3D overlap. Additional CT scans might be obtained intra-operatively if needed to guide the biopsy catheter appropriately towards the lesion. Due to the live nature of the Cone Beam CT, it is much more capable of providing accurate guidance regarding the location of the lesion and the biopsy instruments. hence, in case of any discrepancy, information provided by Cone Beam CT is considered more reliable and used with higher confidence. Rest of the steps involved in procedure are similar between the control and the interventional arm including the surgeon, type of bronchoscopes, type of electromagnetic navigational system, use of peripheral Endobronchial Ultrasound and availability of on-site pathologist. The biopsy instruments used are also the same including transbronchial needle for FNA, Single or triple needle brush and transbronchial forceps. Bronchoalveolar lavage is also obtained at the end via extended working channel. All the patients undergoing biopsy of the peripheral/central lung lesions using ENB also undergo Convex EBUS guided mediastinal surveillance and EBUS-TBFNA of any Lymph Node that appears to be greater than 5 mm on EBUS exam. My study aims to study the effect of using Cone Beam CT with segmentation, 3-D overlay and CT augmented fluoroscopy on sensitivity and diagnostic yield of electromagnetic navigation bronchoscopy for diagnosis of peripheral and central lung lesions including lung nodules and masses which could not be directly accessed using just white light bronchoscope.

Registry
clinicaltrials.gov
Start Date
August 1, 2017
End Date
November 2, 2021
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Columbus Regional Health
Responsible Party
Principal Investigator
Principal Investigator

Deepankar Sharma

Medical Director, Lung Institute and Section Chief, Pulmonary & Critical Care

Columbus Regional Health

Eligibility Criteria

Inclusion Criteria

  • Patients with lung nodule
  • Patients with lung mass
  • Patients undergoing undergoing electromagnetic navigation bronchoscopy for biopsy.

Exclusion Criteria

  • Patients less than 18 years of age
  • Patients unable to complete the electromagnetic navigational bronchoscopy procedure.

Outcomes

Primary Outcomes

Diagnostic Yield

Time Frame: 1 year Follow up. Prelim results to be reviewed at 3 months

Percentage of correct underlying diagnosis

Sensitivity for malignancy

Time Frame: 1 year Follow up. Prelim results to be reviewed at 3 months

Percentage of malignant lesions accurately diagnosed on biopsy

Secondary Outcomes

  • Radiation Exposure(1 year Follow up. Prelim results to be reviewed at 3 months)
  • Procedure Time(1 year Follow up. Prelim results to be reviewed at 3 months)
  • Procedural Complications(1 year Follow up. Prelim results to be reviewed at 3 months)

Study Sites (1)

Loading locations...

Similar Trials